AI in Histopathology to Support Prostate & Breast Cancer Diagnosis | Tenderlake

AI in Histopathology to Support Prostate & Breast Cancer Diagnosis

Contract Value:
1 -
Notice Type:
Prior Information Notice
Published Date:
04 November 2025
Closing Date:
Location(s):
UK UNITED KINGDOM
UKI LONDON (UK UNITED KINGDOM)
Description:
Preliminary market consultation is being conducted to inform the NHS commercial strategy for implementing AI in histopathology to assist in the diagnosis of prostate and breast cancer.
Preliminary market consultation to inform the NHS commercial strategy for AI in Histopathology to Support Prostate & Breast Cancer Diagnosis. Please note all stated financial values in relation to this notice are nominal, as the financial envelope is yet to be defined. Projected contracting dates in the notice, similarly do not reflect any plans as these are yet to be defined. To express interest, review and respond to the request for information questionnaire please register and apply via Atamis e-sourcing portal using the following link. https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Sr00000mIR7PIAW&searchStr=&sortStr=Recently+Published&page=1&filters=&County=


Preliminary Market Consultation regarding AI in Histopathology to Support Prostate & Breast Cancer Diagnosis.
Download full details as .pdf
The Buyer:
NHS England
Additional information:
Link:
Download Full Notice as PDF
Link:
View Notice Source
CPV Code(s):
33110000 - Imaging equipment for medical, dental and veterinary use
33190000 - Miscellaneous medical devices and products
48180000 - Medical software package
72212460 - Analytical, scientific, mathematical or forecasting software development services
85111800 - Pathology services